interesting points for BIO conference After listening to the conference a second time, I noticed that DM had mentioned that sometime in early Q2 they will be announcing the AZ phase 2 clinical trial that will be affilitated by other parties he mentioned. What does other parties mean? Funding through Partnering ? Funding by a Alzheimer non profit association? Or maybe another type of NGN Biotech. Who knows ?
One thing I have realized after a bit of research is any public Biotech company in Phase 2 cliical trials is a minimum $400 million maket cap. That being said RVX is way way under valued to the maket and I think the big insitutions are going to get the picture and it will move up to those levels in the next 3 to 6 months. That could be why Jones trading is involved as they can facilitate large institutinal orders